NSG 533 Advanced Pharmacology Final Exam Questions
and Answers (100% Verified) Actual Exam 2026/2027 |
Complete Exam-Style Questions with Detailed Rationales |
100% Verified | Pass Guaranteed – A+ Graded
Pharmacokinetics and Pharmacodynamics
Q1: A patient with liver failure is prescribed a drug that undergoes extensive first-pass
metabolism. What is the most likely clinical consequence?
A. Decreased bioavailability
B. Increased bioavailability [CORRECT]
C. Faster excretion
D. Decreased receptor binding
Correct Answer: B
Rationale: The best answer is increased bioavailability because liver failure reduces first-pass
metabolism, allowing more active drug to reach systemic circulation.
Q2: Which pharmacokinetic phase is primarily affected when a patient is concurrently taking
a strong CYP3A4 inhibitor?
A. Absorption
B. Distribution
C. Metabolism [CORRECT]
D. Excretion
Correct Answer: C
Rationale: This choice is correct because CYP3A4 is a major hepatic enzyme responsible for
drug metabolism, and its inhibition directly alters this phase.
Q3: A drug has a half-life of 12 hours. Approximately how long will it take to reach steady-
state concentration with regular dosing?
A. 12 hours
B. 24 hours
C. 36 hours
D. 60 hours [CORRECT]
Correct Answer: D
Rationale: This matches the principle that steady state is typically achieved in 4 to 5 half-
lives, which for a 12-hour half-life is 48 to 60 hours.
Q4: A 70-year-old patient experiences prolonged sedation from a standard dose of
diazepam. Which age-related change best explains this?
A. Increased gastric pH
B. Decreased lean body mass and increased fat [CORRECT]
C. Increased renal blood flow
,D. Decreased plasma protein binding
Correct Answer: B
Rationale: This is correct because diazepam is highly lipid-soluble, and increased adipose
tissue in older adults expands the volume of distribution, prolonging its effect.
Q5: What is the primary purpose of a loading dose?
A. To maintain steady-state concentration
B. To rapidly achieve therapeutic drug levels [CORRECT]
C. To reduce drug toxicity
D. To enhance renal excretion
Correct Answer: B
Rationale: The best answer is to rapidly achieve therapeutic drug levels, which is the
defining clinical purpose of administering a loading dose before maintenance dosing.
Q6: A patient develops a rash after taking penicillin. This reaction is an example of which
type of pharmacodynamic response?
A. Idiosyncratic reaction
B. Allergic reaction [CORRECT]
C. Tachyphylaxis
D. Teratogenic effect
Correct Answer: B
Rationale: This aligns with an immune-mediated allergic reaction, which is a classic adverse
response to penicillin unrelated to the drug's primary pharmacologic action.
Q7: Which term describes a drug that binds to a receptor and produces a submaximal
response, even at full receptor occupancy?
A. Full agonist
B. Antagonist
C. Partial agonist [CORRECT]
D. Inverse agonist
Correct Answer: C
Rationale: This choice is correct because a partial agonist inherently has lower intrinsic
efficacy than a full agonist, capping its maximal effect.
Q8: A patient with renal impairment is prescribed a drug that is 90% renally excreted
unchanged. What is the most appropriate action?
A. Increase the dose frequency
B. Decrease the dose or extend the dosing interval [CORRECT]
C. Switch to an intramuscular route
D. Add a CYP450 inducer
Correct Answer: B
Rationale: This matches the principle that renally cleared drugs require dose adjustments in
renal impairment to prevent toxic accumulation.
Q9: Which pharmacokinetic parameter represents the fraction of an administered dose that
reaches the systemic circulation unchanged?
A. Volume of distribution
, B. Clearance
C. Bioavailability [CORRECT]
D. Half-life
Correct Answer: C
Rationale: The best answer is bioavailability, as it specifically defines the proportion of the
drug that enters systemic circulation intact after administration.
Q10: A patient takes drug A, which displaces drug B from plasma albumin. Drug B is highly
protein-bound. What is the immediate effect on drug B?
A. Decreased free drug concentration
B. Increased free drug concentration and potential toxicity [CORRECT]
C. Increased metabolism of drug B
D. Decreased volume of distribution
Correct Answer: B
Rationale: This is correct because displacing a highly protein-bound drug increases its free,
active fraction, raising the risk of adverse effects or toxicity.
Q11: Which route of administration avoids first-pass metabolism entirely?
A. Oral
B. Sublingual [CORRECT]
C. Rectal
D. Enteral
Correct Answer: B
Rationale: This choice is correct because sublingual administration allows the drug to absorb
directly into the systemic circulation via the oral mucosa, bypassing the liver.
Q12: A drug's therapeutic index is calculated as the ratio of:
A. ED50 to LD50
B. LD50 to ED50 [CORRECT]
C. Clearance to volume of distribution
D. Peak concentration to trough concentration
Correct Answer: B
Rationale: This aligns with the standard pharmacological definition where a higher ratio
(LD50/ED50) indicates a safer drug with a wider margin of safety.
Q13: A patient is prescribed a prodrug. What must occur for this medication to become
clinically active?
A. It must be excreted unchanged by the kidneys.
B. It must undergo metabolic conversion in the body. [CORRECT]
C. It must bind to plasma proteins first.
D. It must be administered intravenously.
Correct Answer: B
Rationale: The best answer is metabolic conversion, as prodrugs are pharmacologically
inactive until enzymatic processes transform them into their active metabolites.
Q14: Which factor most significantly contributes to variable drug response among different
ethnic populations?
and Answers (100% Verified) Actual Exam 2026/2027 |
Complete Exam-Style Questions with Detailed Rationales |
100% Verified | Pass Guaranteed – A+ Graded
Pharmacokinetics and Pharmacodynamics
Q1: A patient with liver failure is prescribed a drug that undergoes extensive first-pass
metabolism. What is the most likely clinical consequence?
A. Decreased bioavailability
B. Increased bioavailability [CORRECT]
C. Faster excretion
D. Decreased receptor binding
Correct Answer: B
Rationale: The best answer is increased bioavailability because liver failure reduces first-pass
metabolism, allowing more active drug to reach systemic circulation.
Q2: Which pharmacokinetic phase is primarily affected when a patient is concurrently taking
a strong CYP3A4 inhibitor?
A. Absorption
B. Distribution
C. Metabolism [CORRECT]
D. Excretion
Correct Answer: C
Rationale: This choice is correct because CYP3A4 is a major hepatic enzyme responsible for
drug metabolism, and its inhibition directly alters this phase.
Q3: A drug has a half-life of 12 hours. Approximately how long will it take to reach steady-
state concentration with regular dosing?
A. 12 hours
B. 24 hours
C. 36 hours
D. 60 hours [CORRECT]
Correct Answer: D
Rationale: This matches the principle that steady state is typically achieved in 4 to 5 half-
lives, which for a 12-hour half-life is 48 to 60 hours.
Q4: A 70-year-old patient experiences prolonged sedation from a standard dose of
diazepam. Which age-related change best explains this?
A. Increased gastric pH
B. Decreased lean body mass and increased fat [CORRECT]
C. Increased renal blood flow
,D. Decreased plasma protein binding
Correct Answer: B
Rationale: This is correct because diazepam is highly lipid-soluble, and increased adipose
tissue in older adults expands the volume of distribution, prolonging its effect.
Q5: What is the primary purpose of a loading dose?
A. To maintain steady-state concentration
B. To rapidly achieve therapeutic drug levels [CORRECT]
C. To reduce drug toxicity
D. To enhance renal excretion
Correct Answer: B
Rationale: The best answer is to rapidly achieve therapeutic drug levels, which is the
defining clinical purpose of administering a loading dose before maintenance dosing.
Q6: A patient develops a rash after taking penicillin. This reaction is an example of which
type of pharmacodynamic response?
A. Idiosyncratic reaction
B. Allergic reaction [CORRECT]
C. Tachyphylaxis
D. Teratogenic effect
Correct Answer: B
Rationale: This aligns with an immune-mediated allergic reaction, which is a classic adverse
response to penicillin unrelated to the drug's primary pharmacologic action.
Q7: Which term describes a drug that binds to a receptor and produces a submaximal
response, even at full receptor occupancy?
A. Full agonist
B. Antagonist
C. Partial agonist [CORRECT]
D. Inverse agonist
Correct Answer: C
Rationale: This choice is correct because a partial agonist inherently has lower intrinsic
efficacy than a full agonist, capping its maximal effect.
Q8: A patient with renal impairment is prescribed a drug that is 90% renally excreted
unchanged. What is the most appropriate action?
A. Increase the dose frequency
B. Decrease the dose or extend the dosing interval [CORRECT]
C. Switch to an intramuscular route
D. Add a CYP450 inducer
Correct Answer: B
Rationale: This matches the principle that renally cleared drugs require dose adjustments in
renal impairment to prevent toxic accumulation.
Q9: Which pharmacokinetic parameter represents the fraction of an administered dose that
reaches the systemic circulation unchanged?
A. Volume of distribution
, B. Clearance
C. Bioavailability [CORRECT]
D. Half-life
Correct Answer: C
Rationale: The best answer is bioavailability, as it specifically defines the proportion of the
drug that enters systemic circulation intact after administration.
Q10: A patient takes drug A, which displaces drug B from plasma albumin. Drug B is highly
protein-bound. What is the immediate effect on drug B?
A. Decreased free drug concentration
B. Increased free drug concentration and potential toxicity [CORRECT]
C. Increased metabolism of drug B
D. Decreased volume of distribution
Correct Answer: B
Rationale: This is correct because displacing a highly protein-bound drug increases its free,
active fraction, raising the risk of adverse effects or toxicity.
Q11: Which route of administration avoids first-pass metabolism entirely?
A. Oral
B. Sublingual [CORRECT]
C. Rectal
D. Enteral
Correct Answer: B
Rationale: This choice is correct because sublingual administration allows the drug to absorb
directly into the systemic circulation via the oral mucosa, bypassing the liver.
Q12: A drug's therapeutic index is calculated as the ratio of:
A. ED50 to LD50
B. LD50 to ED50 [CORRECT]
C. Clearance to volume of distribution
D. Peak concentration to trough concentration
Correct Answer: B
Rationale: This aligns with the standard pharmacological definition where a higher ratio
(LD50/ED50) indicates a safer drug with a wider margin of safety.
Q13: A patient is prescribed a prodrug. What must occur for this medication to become
clinically active?
A. It must be excreted unchanged by the kidneys.
B. It must undergo metabolic conversion in the body. [CORRECT]
C. It must bind to plasma proteins first.
D. It must be administered intravenously.
Correct Answer: B
Rationale: The best answer is metabolic conversion, as prodrugs are pharmacologically
inactive until enzymatic processes transform them into their active metabolites.
Q14: Which factor most significantly contributes to variable drug response among different
ethnic populations?
